163 related articles for article (PubMed ID: 38271114)
21. miR-145-5p Targets Sp1 in Non-Small Cell Lung Cancer Cells and Links to BMI1 Induced Pemetrexed Resistance and Epithelial-Mesenchymal Transition.
Chang WW; Wang BY; Chen SH; Chien PJ; Sheu GT; Lin CH
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499676
[TBL] [Abstract][Full Text] [Related]
22. LINC81507 act as a competing endogenous RNA of miR-199b-5p to facilitate NSCLC proliferation and metastasis via regulating the CAV1/STAT3 pathway.
Peng W; He D; Shan B; Wang J; Shi W; Zhao W; Peng Z; Luo Q; Duan M; Li B; Cheng Y; Dong Y; Tang F; Zhang C; Duan C
Cell Death Dis; 2019 Jul; 10(7):533. PubMed ID: 31296840
[TBL] [Abstract][Full Text] [Related]
23. Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer.
Wang L; Tong X; Zhou Z; Wang S; Lei Z; Zhang T; Liu Z; Zeng Y; Li C; Zhao J; Su Z; Zhang C; Liu X; Xu G; Zhang HT
Mol Cancer; 2018 Sep; 17(1):140. PubMed ID: 30261900
[TBL] [Abstract][Full Text] [Related]
24. Long Non-Coding RNA Prostate Cancer-Associated Transcript 7 (PCAT7) Induces Poor Prognosis and Promotes Tumorigenesis by Inhibiting mir-134-5p in Non-Small-Cell Lung (NSCLC).
Liu Q; Wu Y; Xiao J; Zou J
Med Sci Monit; 2017 Dec; 23():6089-6098. PubMed ID: 29275424
[TBL] [Abstract][Full Text] [Related]
25. miR-942 promotes tumor migration, invasion, and angiogenesis by regulating EMT via BARX2 in non-small-cell lung cancer.
Yang F; Shao C; Wei K; Jing X; Qin Z; Shi Y; Shu Y; Shen H
J Cell Physiol; 2019 Dec; 234(12):23596-23607. PubMed ID: 31236953
[TBL] [Abstract][Full Text] [Related]
26. TNFAIP2 Promotes Non-Small Cell Lung Cancer Cells and Targeted by miR-145-5p.
Li J; Song Y; Yu B; Yu Y
DNA Cell Biol; 2020 Jul; 39(7):1256-1263. PubMed ID: 32456459
[TBL] [Abstract][Full Text] [Related]
27. Suppression of CX3CL1 by miR-497-5p inhibits cell growth and invasion through inactivating the ERK/AKT pathway in NSCLC cells.
Tang W; Jia P; Zuo L; Zhao J
Cell Cycle; 2022 Aug; 21(16):1697-1709. PubMed ID: 35485293
[TBL] [Abstract][Full Text] [Related]
28. LncRNA MAFG-AS1 facilitates the migration and invasion of NSCLC cell via sponging miR-339-5p from MMP15.
Jia YC; Wang JY; Liu YY; Li B; Guo H; Zang AM
Cell Biol Int; 2019 Apr; 43(4):384-393. PubMed ID: 30599080
[TBL] [Abstract][Full Text] [Related]
29. Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers.
Chen J; Gao S; Wang C; Wang Z; Zhang H; Huang K; Zhou B; Li H; Yu Z; Wu J; Chen C
J Exp Clin Cancer Res; 2016 Nov; 35(1):173. PubMed ID: 27821145
[TBL] [Abstract][Full Text] [Related]
30. MiR-338 regulates NFATc1 expression and inhibits the proliferation and epithelial-mesenchymal transition of human non-small-cell lung cancer cells.
He W; Lu J
Mol Genet Genomic Med; 2020 Feb; 8(2):e1091. PubMed ID: 31823518
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-331-3p inhibits epithelial-mesenchymal transition by targeting ErbB2 and VAV2 through the Rac1/PAK1/β-catenin axis in non-small-cell lung cancer.
Li X; Zhu J; Liu Y; Duan C; Chang R; Zhang C
Cancer Sci; 2019 Jun; 110(6):1883-1896. PubMed ID: 30955235
[TBL] [Abstract][Full Text] [Related]
32. ALG3 contributes to the malignancy of non-small cell lung cancer and is negatively regulated by MiR-98-5p.
Ke SB; Qiu H; Chen JM; Shi W; Han C; Gong Y; Chen YS
Pathol Res Pract; 2020 Mar; 216(3):152761. PubMed ID: 31899049
[TBL] [Abstract][Full Text] [Related]
33. miR-497-5p inhibits tumor cell growth and invasion by targeting SOX5 in non-small-cell lung cancer.
Li G; Wang K; Wang J; Qin S; Sun X; Ren H
J Cell Biochem; 2019 Jun; 120(6):10587-10595. PubMed ID: 30816573
[TBL] [Abstract][Full Text] [Related]
34. Knockdown of LncRNA-XIST Suppresses Proliferation and TGF-β1-Induced EMT in NSCLC Through the Notch-1 Pathway by Regulation of miR-137.
Wang X; Zhang G; Cheng Z; Dai L; Jia L; Jing X; Wang H; Zhang R; Liu M; Jiang T; Yang Y; Yang M
Genet Test Mol Biomarkers; 2018 Jun; 22(6):333-342. PubMed ID: 29812958
[TBL] [Abstract][Full Text] [Related]
35. Suppression of MGAT3 expression and the epithelial-mesenchymal transition of lung cancer cells by miR-188-5p.
Niu H; Qu A; Guan C
Biomed J; 2021 Dec; 44(6):678-685. PubMed ID: 35166206
[TBL] [Abstract][Full Text] [Related]
36. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene.
Li Y; Zhang H; Li Y; Zhao C; Fan Y; Liu J; Li X; Liu H; Chen J
Mol Carcinog; 2018 Jan; 57(1):125-136. PubMed ID: 28940757
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
38. Circular RNA hsa_circ_0004689 (circSWT1) promotes NSCLC progression via the miR-370-3p/SNAIL axis by inducing cell epithelial-mesenchymal transition (EMT).
Long X; Wang DG; Wu ZB; Liao ZM; Xu JJ
Cancer Med; 2023 Apr; 12(7):8289-8305. PubMed ID: 36530171
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of miR-455-3 in suppressing epithelial-mesenchymal transition and angiogenesis of non-small cell lung cancer cells.
Meng C; Liu K; Cai X; Chen Y
Cell Stress Chaperones; 2021 Mar; 27(2):107-117. PubMed ID: 35064898
[TBL] [Abstract][Full Text] [Related]
40. Sulforaphane suppresses EMT and metastasis in human lung cancer through miR-616-5p-mediated GSK3β/β-catenin signaling pathways.
Wang DX; Zou YJ; Zhuang XB; Chen SX; Lin Y; Li WL; Lin JJ; Lin ZQ
Acta Pharmacol Sin; 2017 Feb; 38(2):241-251. PubMed ID: 27890917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
